The Centers for Medicare & Medicaid Services issued a final coverage decision for transcatheter mitral valve replacement devices, a decision that currently only affects Abbott’s (NYSE:ABT) MitraClip implant.
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
St. Jude and Volcano call a cease-fire
Boston Scientific reveals federal probe of BridgePoint buy, sales
Boston Scientific (NYSE:BSX) informed investors this week that it’s under investigation by the U.S. Attorney for the District of New Jersey over a cardiology devices company acquired 2 years ago.
Abbott’s MitraClip, St. Jude’s CardioMEMS land new Medicare coverage
TAVI study: Sapien tops CoreValve in AR risk, but is CoreValve safer?
CardioMEMS’ 11-year payoff worth the wait for Boston Millennia Partners
The CardioMEMS story didn’t end when St. Jude Medical (NYSE:STJ) acquired the Georgia-based company in June, paying $375 million for the stake it didn’t already own, valuing the implantable heart failure monitor company at $463 million total.
Edwards: Q2 brings double-digit sales bump, a major Medtronic settlement and a rosier outlook on the year
Edwards Lifesciences (NYSE:EW) bumped its expectations for the year after posting a strong 2nd quarter with significant increases in its sales and profits.
Medtech’s top stent-makers land SharedClarity contracts
Four of medtech’s biggest firms agreed to offer peripheral stents at specialized prices to members of SharedClarity, an organization formed through the alliance of some of the country’s largest health insurance and care providers.
Press Release: Sorin Group announces CE Mark approval for Crown PRT heart valve
Milan, Italy – Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today it has been granted CE mark certification for its innovative stented aortic bioprosthesis Crown PRT, now commercially available in Europe.
Sorin touts E.U. approval for next-gen heart valve
Sorin Group (BIT:SRN) announced this week that it landed European CE Mark approval for its latest aortic heart valve, the Crown PRT.